Erin Wright
Stock Analyst at Morgan Stanley
(4.48)
# 267
Out of 5,093 analysts
242
Total ratings
63.58%
Success rate
14.57%
Average return
Main Sectors:
Stocks Rated by Erin Wright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZTS Zoetis | Maintains: Overweight | $211 → $175 | $115.75 | +51.19% | 8 | Nov 10, 2025 | |
| MCK McKesson | Maintains: Overweight | $857 → $916 | $795.01 | +15.22% | 10 | Nov 6, 2025 | |
| HSIC Henry Schein | Maintains: Underweight | $55 → $58 | $74.44 | -22.08% | 5 | Nov 5, 2025 | |
| IDXX IDEXX Laboratories | Maintains: Overweight | $765 → $805 | $699.06 | +15.15% | 19 | Nov 4, 2025 | |
| ALGN Align Technology | Maintains: Equal-Weight | $142 → $154 | $159.00 | -3.14% | 25 | Oct 30, 2025 | |
| OPCH Option Care Health | Initiates: Overweight | $35 | $32.22 | +8.63% | 1 | Oct 17, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $163 → $204 | $156.88 | +30.04% | 3 | Oct 14, 2025 | |
| ELV Elevance Health | Maintains: Equal-Weight | $316 → $359 | $329.81 | +8.85% | 4 | Oct 14, 2025 | |
| CVS CVS Health | Maintains: Overweight | $82 → $89 | $78.24 | +13.75% | 6 | Oct 14, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Overweight | $25 → $32 | $35.43 | -9.68% | 4 | Oct 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $128 → $140 | $139.88 | +0.09% | 2 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $20.62 | -17.56% | 9 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $290 → $277 | $250.39 | +10.63% | 4 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $313 → $330 | $337.29 | -2.16% | 1 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $181 → $190 | $198.00 | -4.04% | 12 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $26 | $38.28 | -32.08% | 23 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $379 → $390 | $262.71 | +48.45% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $3.5 → $3.2 | $1.61 | +98.76% | 12 | Apr 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $14 → $13 | $20.43 | -36.37% | 11 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $23 | $11.11 | +107.02% | 12 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $145 → $172 | $179.62 | -4.24% | 5 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $587 | $323.60 | +81.40% | 3 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Overweight | $300 | $258.06 | +16.25% | 4 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $39 → $42 | $10.63 | +295.11% | 5 | Jul 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $282 → $288 | $223.23 | +29.01% | 6 | Jun 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $342 → $352 | $185.99 | +89.26% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $42 → $44 | $3.69 | +1,092.41% | 2 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $178 → $181 | $544.08 | -66.73% | 8 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $60.88 | -72.08% | 6 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $121 | $34.84 | +247.30% | 7 | Jan 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $556 → $580 | $563.07 | +3.01% | 4 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $35 | $9.17 | +281.68% | 1 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $181 → $205 | $181.29 | +13.08% | 2 | Jul 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $12 → $11 | $27.46 | -59.94% | 6 | May 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $157 | $218.06 | -28.00% | 1 | Apr 2, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $31 → $17 | $2.49 | +582.73% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $300 → $308 | $466.89 | -34.03% | 1 | Oct 25, 2017 |
Zoetis
Nov 10, 2025
Maintains: Overweight
Price Target: $211 → $175
Current: $115.75
Upside: +51.19%
McKesson
Nov 6, 2025
Maintains: Overweight
Price Target: $857 → $916
Current: $795.01
Upside: +15.22%
Henry Schein
Nov 5, 2025
Maintains: Underweight
Price Target: $55 → $58
Current: $74.44
Upside: -22.08%
IDEXX Laboratories
Nov 4, 2025
Maintains: Overweight
Price Target: $765 → $805
Current: $699.06
Upside: +15.15%
Align Technology
Oct 30, 2025
Maintains: Equal-Weight
Price Target: $142 → $154
Current: $159.00
Upside: -3.14%
Option Care Health
Oct 17, 2025
Initiates: Overweight
Price Target: $35
Current: $32.22
Upside: +8.63%
Molina Healthcare
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $163 → $204
Current: $156.88
Upside: +30.04%
Elevance Health
Oct 14, 2025
Maintains: Equal-Weight
Price Target: $316 → $359
Current: $329.81
Upside: +8.85%
CVS Health
Oct 14, 2025
Maintains: Overweight
Price Target: $82 → $89
Current: $78.24
Upside: +13.75%
BrightSpring Health Services
Oct 14, 2025
Maintains: Overweight
Price Target: $25 → $32
Current: $35.43
Upside: -9.68%
Oct 3, 2025
Maintains: Equal-Weight
Price Target: $128 → $140
Current: $139.88
Upside: +0.09%
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $20.62
Upside: -17.56%
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $290 → $277
Current: $250.39
Upside: +10.63%
Jul 16, 2025
Maintains: Equal-Weight
Price Target: $313 → $330
Current: $337.29
Upside: -2.16%
Jul 16, 2025
Maintains: Overweight
Price Target: $181 → $190
Current: $198.00
Upside: -4.04%
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $21 → $26
Current: $38.28
Upside: -32.08%
May 5, 2025
Maintains: Overweight
Price Target: $379 → $390
Current: $262.71
Upside: +48.45%
Apr 17, 2025
Maintains: Underweight
Price Target: $3.5 → $3.2
Current: $1.61
Upside: +98.76%
Feb 26, 2025
Maintains: Equal-Weight
Price Target: $14 → $13
Current: $20.43
Upside: -36.37%
Dec 17, 2024
Maintains: Overweight
Price Target: $30 → $23
Current: $11.11
Upside: +107.02%
Dec 17, 2024
Upgrades: Overweight
Price Target: $145 → $172
Current: $179.62
Upside: -4.24%
Jul 14, 2023
Reiterates: Overweight
Price Target: $587
Current: $323.60
Upside: +81.40%
Aug 22, 2022
Assumes: Overweight
Price Target: $300
Current: $258.06
Upside: +16.25%
Jul 30, 2021
Maintains: Outperform
Price Target: $39 → $42
Current: $10.63
Upside: +295.11%
Jun 18, 2021
Maintains: Outperform
Price Target: $282 → $288
Current: $223.23
Upside: +29.01%
May 28, 2021
Maintains: Neutral
Price Target: $342 → $352
Current: $185.99
Upside: +89.26%
May 11, 2021
Maintains: Outperform
Price Target: $42 → $44
Current: $3.69
Upside: +1,092.41%
Mar 17, 2021
Maintains: Outperform
Price Target: $178 → $181
Current: $544.08
Upside: -66.73%
Feb 26, 2021
Maintains: Neutral
Price Target: $14 → $17
Current: $60.88
Upside: -72.08%
Jan 13, 2021
Maintains: Outperform
Price Target: $104 → $121
Current: $34.84
Upside: +247.30%
Jan 12, 2021
Maintains: Outperform
Price Target: $556 → $580
Current: $563.07
Upside: +3.01%
Jan 5, 2021
Initiates: Neutral
Price Target: $35
Current: $9.17
Upside: +281.68%
Jul 23, 2020
Maintains: Outperform
Price Target: $181 → $205
Current: $181.29
Upside: +13.08%
May 5, 2020
Maintains: Neutral
Price Target: $12 → $11
Current: $27.46
Upside: -59.94%
Apr 2, 2020
Maintains: Outperform
Price Target: $175 → $157
Current: $218.06
Upside: -28.00%
Nov 20, 2017
Maintains: Underperform
Price Target: $31 → $17
Current: $2.49
Upside: +582.73%
Oct 25, 2017
Maintains: Neutral
Price Target: $300 → $308
Current: $466.89
Upside: -34.03%